Author (Corporate) | European Commission: DG Communication |
---|---|
Series Title | Press Release |
Series Details | IP/12/457 (08.05.12) |
Publication Date | 08/05/2012 |
Content Type | News |
The European Commission has concluded that €23 million public funding, which Italy intends to grant to Novartis Vaccines & Diagnostics S.r.l. (NV&D) for the research and development of innovative vaccines, is in line with EU state aid rules, in particular because it tackles a genuine market failure and stimulates research in the EU. The project aims at ensuring that developing countries gain quicker access to such innovative products at affordable prices. |
|
Source Link | http://europa.eu/rapid/pressReleasesAction.do?reference=IP/12/457&format=HTML&aged=0&language=EN&guiLanguage=en |
Subject Categories | Internal Markets |
Countries / Regions | Europe, Norway |
![](https://www.europeansources.info/wp-content/uploads/esologo2.png)